Calmodulin is associated with microtubules forming in PTK1 cells upon release from nocodazole treatment.
To investigate the association of calmodulin (CaM) with microtubules (MTs) in the mitotic apparatus (MA), the distributions of CaM and tubulin were examined in cells in which the normal spindle organization had been altered. A fluorescent CaM conjugate with tetramethylrhodamine isothiocyanate (CaM-TRITC) and a dichlorotriazinyl aminofluorescein conjugate with tubulin (tubulin-DTAF) were injected into cells that had been treated with the MT inhibitor nocodazole. With moderate nocodazole concentration (0.3 micrograms/ml, 37 degrees C, 4 h) in live cells, CaM-TRITC and tubulin-DTAF concentrated identically on or near the centrosomes and kinetochores. In serial sections of these cells, small MT segments were observed by transmission electron microscopy (TEM) in the regions where fluorescent protein had concentrated. When a higher drug concentration was used (3.0 micrograms/ml, 37 degrees C, 4 h), no regions of CaM-TRITC or tubulin-DTAF localization were observed, and no MTs were observed when serial sections were examined by TEM. However, following release from the high-concentration nocodazole block, CaM-TRITC colocalized with newly formed MTs at the kinetochores and centrosomes. Later in the recovery period, when chromosome-to-pole fibers had formed, CaM association with kinetochores diminished, ultimately attaining its normal pole-proximal association with kinetochore MTs in cells that progressed through mitosis. We interpret these observations as supporting the hypothesis that in the MA, CaM attains a physical association with kinetochore MTs and suggest that CaM-associated MTs may be inherently more stable.
Sweet
S C
SC
Department of Anatomy and Cell Biology, University of Michigan Medical School, Ann Arbor 48109-0616.
Rogers
C M
CM
Welsh
M J
MJ
D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology*; D002147:Calmodulin / Q000378:metabolism*; D002478:Cells, Cultured; D002502:Centrioles / Q000187:drug effects / Q000378:metabolism; D003599:Cytoskeleton / Q000187:drug effects / Q000378:metabolism; D005452:Fluoresceins; D008856:Microscopy, Fluorescence; D008870:Microtubules / Q000187:drug effects / Q000378:metabolism*; D015739:Nocodazole; D015388:Organelles / Q000187:drug effects / Q000378:metabolism; D012235:Rhodamines; D013997:Time Factors; D014404:Tubulin
D001562:Benzimidazoles; D002147:Calmodulin; D005452:Fluoresceins; D012235:Rhodamines; D014404:Tubulin; C039083:5-((4,6-dichloro-1,3,5-triazin-2-yl)amino)fluorescein; C009434:tetramethylrhodamine isothiocyanate; D015739:Nocodazole